"In combination with diet and exercise, Wegovy is the only obesity medicine proven to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight
Lipoprotein (a) is not associated with lifestyle factors but is considered to have additive ASCVD risk to BMI [17]
Its one of the few FDA-approved options that also addresses the psychological and behavioral side of overeating, not just physical hunger
Read more Sabrina Malek-Ghetti, Esq
Your PlexusDx provider can explore alternatives like tirzepatide (a dual GLP-1/GIP compound) or the GLP-Squared combination injection, both at $289/mo month-to-month, or from $249/mo on the 3-month plan
It is built on a guiding principle of using the lowest effective dose first